Singapore markets close in 2 hours 29 minutes

Vincerx Pharma, Inc. (VINC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9300-0.0200 (-2.11%)
At close: 04:00PM EDT
0.9650 +0.04 (+3.76%)
After hours: 07:45PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
28,973
28,973
49,837
40,081
7,116
Selling general and administrative
13,636
13,636
18,885
22,575
3,598
Total operating expenses
42,609
42,609
68,722
62,656
10,714
Operating income or loss
-42,609
-42,609
-68,722
-62,656
-10,714
Interest expense
-
-
-
-
8
Total other income/expenses net
1,201
1,201
5,074
23,350
-5,144
Income before tax
-40,157
-40,157
-62,984
-39,306
-16,620
Income from continuing operations
-40,157
-40,157
-62,984
-39,306
-16,620
Net income
-40,157
-40,157
-62,984
-39,306
-16,620
Net income available to common shareholders
-40,157
-40,157
-62,984
-39,306
-16,620
Basic EPS
-2.31
-
-3.00
-2.29
-3.16
Diluted EPS
-2.31
-
-3.00
-2.29
-3.16
Basic average shares
21,237
-
21,029
17,176
5,252
Diluted average shares
21,237
-
21,029
17,176
5,252